<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Bulletin of Semashko National Research Institute of Public Health</journal-id><journal-title-group><journal-title>Bulletin of Semashko National Research Institute of Public Health</journal-title></journal-title-group><issn publication-format="print">2415-8410</issn><issn publication-format="electronic">2415-8429</issn><publisher><publisher-name>FSSBI «N.A. Semashko National Research Institute of Public Health»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1727</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>ANTITHROMBOTIC THERAPY OF IN-PATIENTS WITH ISCHEMIC STROKE</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Oleynikova</surname><given-names>T. A</given-names></name><bio></bio><email>ol_tanja@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Titova</surname><given-names>A. A</given-names></name><bio></bio><email>annadreu@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1"></aff><pub-date date-type="epub" iso-8601-date="2017-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2017</year></pub-date><issue>1</issue><fpage>199</fpage><lpage>202</lpage><history><pub-date date-type="received" iso-8601-date="2022-04-14"><day>14</day><month>04</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2017,</copyright-statement><copyright-year>2017</copyright-year></permissions><abstract>Technologies of antithrombotic therapy of patients with ischemic stroke have been considered taking into account recommendations of medical aid standard and patients managing protocol. Structure of mono-and combined indications of international non-patented names in hospital conditions is presented.</abstract><kwd-group xml:lang="en"><kwd>antithrombotic therapy</kwd><kwd>ischemic stroke</kwd><kwd>international nonpatented names</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>антитромботическая терапия</kwd><kwd>ишемический инсульт</kwd><kwd>международные непатентованные наименования</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>ГОСТ Р 52600.5-2008. Протокол ведения больных. Инсульт. - М.: Стандартинформ, 2009. - 160 с.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Клинические рекомендации по проведению тромболитической терапии у пациентов с ишемическим инсультом: утверждены решением Президиума Всероссийского общества неврологов 17.05.2015 г. - 49 с. - http://minzdrav.saratov.gov.ru.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Парфенов В.А., Хасанова Д.Р. Ишемический инсульт. - М.: МИА, 2012. - 288 с.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Приказ Министерства здравоохранения и социального развития Российской Федерации от 01.08.2007 г. № 513 «Об утверждении стандарта медицинской помощи больным с инсультом (при оказании специализированной помощи)» -http://client.consultant.ru/2C25FB8F7E1BF42BF473E677F8B2E877/doc.</mixed-citation></ref></ref-list></back></article>
